Mylan selling generic version of Pfizer's Detrol

Associated Press Modified: November 29, 2012 at 12:19 pm •  Published: November 29, 2012
Advertisement
;

PITTSBURGH (AP) — Mylan Inc. said Thursday that it is now selling a generic version of Pfizer Inc.'s overactive bladder drug Detrol.

The company said it started shipping its generic after receiving approval from the Food and Drug Administration. It said U.S. sales of Detrol, or tolterodine, totaled $61.5 million over the year ended Sept. 30.

Mylan plans to start selling a generic version of Detrol LA, a long-acting version of the drug, in early 2014 as part of an agreement with Pfizer. Annual U.S. sales of Detrol LA are around $600 million.

Shares of Pittsburgh-based Mylan rose 13 cents to $27.32 in midday trading after rising as high as $27.45 earlier in the session, its highest since October 2003.


Advertisement


Trending Now



AROUND THE WEB

  1. 1
    Dave Chappelle Reveals Shockingly Buff New Look
  2. 2
    Peaches Geldof Funeral to Be Held on Easter Monday
  3. 3
    Mayor Who Fired Lesbian Police Chief Caught On Tape In Homophobic Tirade
  4. 4
    NBA commissioner wants to raise age limit to 20
  5. 5
    Dream guitars I wouldn't mind calling my own (34 Photos)
+ show more